Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
With this, the company can start selling Ibuprofen in the European markets.
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Advancing to IND-enabling studies with multiple drug candidates
Novavax’ clinical development program reported no severe allergic reactions
Plant is part of the company's CAD $30 million capital investment in the site
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
Subscribe To Our Newsletter & Stay Updated